Sarcoma in a Patient with Laryngeal Papillomatosis: A Case Report

Document Type : Case Report

Authors

1 Department of Head and Neck Surgery, Aristotle University of Thessaloniki, Papageorgiou Hospital, Thessaloniki, Greece.

2 2nd Academic ORL - Head and Neck Surgery Department Aristotle University of Thessaloniki Papageorgiou Hospital Thessaloniki, Greece

3 Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece

Abstract

Introduction:
Recurrent respiratory papillomatosis (RRP) is classically described as a benign neoplasm of the larynx. Nevertheless, transformation to dysplasia and invasive carcinoma can occur. Sarcoma of the larynx is rare. Here, we present a case of sarcoma in a patient repeatedly treated for RRP.
 
Case Report:
We report a case of a 73- year old Caucasian male diagnosed with adult-onset recurrent respiratory papillomatosis (AORRP) at the age of 63y. o. During the previous 10 years, he underwent multiple surgeries. In the last therapeutic intervention, he was treated with laser excision of the papilloma and topical mitomycin application. Two months after treatment, papilloma recurred and sarcoma was diagnosed.
Conclusions:
RRP is a benign lesion.  Affected patients usually require multiple interventions. It rarely degenerates to malignancy. Sarcoma in the larynx in the presence of RRP is a rare case. Extended surgical removal remains the treatment of choice. Adjuvant therapies consist of chemotherapy and radiation and are reserved for unresectable or recurrent cases.

Keywords

References

  1. Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, Castellsagué X. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012, 30: 34-54.
  2. Kanazawa T, Fukushima N, Imayoshi S, et al. Rare case of malignant transformation of recurrent respiratory papillomatosis associated with human papillomavirus type 6 infection and p53 overexpression. Springerplus. 2013, 2(1):153.
  3. Pakkanen PP, Aaltonen LM, Sorsa TA, Tervahartiala Taina I, Hagström Jaana K, Ilmarinen  Taru T. Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1:  Potential  markers

 

for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer. Head Neck. 2019, 41(2):309-314.  10.1002 /hed.25459

  1. Hamza AH, Nasr MM, Deghady AA. The use of mitomycin-C for respiratory papillomas: clinical, histologic and biochemical correlation. Saudi Med J. 2005, 26(11):1737-45.
  2. Egbert J. D. Veen, Frederik G. Dikkers. Topical use of MMC in the upper aerodigestive tract: a review on the side effects. Eur Arch Otorhinolaryngol. 2010, 267(3): 327–334.
  3. Agrawal N, Morrison GA. Laryngeal cancer after topical mitomycin C application. J Laryngol Otol. 2006, 120(12):1075-6.
  4. Ramdulari AV, Izzuddeen Y, Benson R, Mallick S, Venkatesulu B, Giridhar P. Laryngeal soft tissue sarcoma: A systematic review and individual patient data analysis of 300 cases. Head Neck. 2021.
  5. Mantilla JG, Xu H, Ricciotti RW. Primary Sarcomas of the Larynx: A Single Institutional Experience with Ten Cases. Head Neck Pathol. 2020, 14(3):707-714.
  6. Liu W, Jiang Q, Zhou Y. Advances of systemic treatment for adult soft-tissue sarcoma. Chin ClinOncol. 2018, 7(4):42.
Iranian Journal of Otorhinolaryngology
Volume 34, Issue 1
January and February 2022
Pages 59-62

Files

Share

How to cite

Statistics